O
RXST icon

OrbiMed’s RxSight RXST Stock Holding History

OrbiMed’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,202,833
Closed -$20.1M – 134
2023
Q1 		$20.1M Hold
1,202,833
– – 0.39% 66
2022
Q4 		$15.2M Hold
1,202,833
– – 0.29% 69
2022
Q3 		$14.4K Sell
1,202,833
-180,667
-13% -$2.48M 0.27% 77
2022
Q2 		$19.5K Hold
1,383,500
– – 0.35% 63
2022
Q1 		$17.1M Hold
1,383,500
– – 0.28% 72
2021
Q4 		$15.6M Buy
1,383,500
+133,500
+11% +$1.6M 0.2% 98
2021
Q3 		$15.8M Buy
+1,250,000
New +$17.2M 0.17% 107

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return